EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.B15 | Fe2+ | activates | Acinetobacter baumannii | |
3.5.1.B15 | Mn2+ | activates | Acinetobacter baumannii | |
3.5.1.B15 | additional information | PncA is a divalent cation-dependent enzyme | Acinetobacter baumannii | |
3.5.1.B15 | Zn2+ | activates, best cation, the active site Cys159 is located at the N-terminus of a6 at one side of the active site with the Zn2+ ion positioned on the other side. The metal ion is bound tightly in the AbPncA active site | Acinetobacter baumannii | |
3.5.1.19 | Fe2+ | activates | Acinetobacter baumannii | |
3.5.1.19 | Mn2+ | activates | Acinetobacter baumannii | |
3.5.1.19 | additional information | PncA is a divalent cation-dependent enzyme | Acinetobacter baumannii | |
3.5.1.19 | Zn2+ | activates, best cation, the active site Cys159 is located at the N-terminus of a6 at one side of the active site with the Zn2+ ion positioned on the other side. The metal ion is bound tightly in the AbPncA active site | Acinetobacter baumannii |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.5.1.B15 | 47000 | - |
gel filtratrion and analytical ultracentrifugation | Acinetobacter baumannii |
3.5.1.19 | 47000 | - |
gel filtratrion and analytical ultracentrifugation | Acinetobacter baumannii |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.B15 | pyrazinamide + H2O | Acinetobacter baumannii | a nicotinamide prodrug. In Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid | pyrazinoic acid + NH3 | a bacteriostatic drug | ? | |
3.5.1.19 | nicotinamide + H2O | Acinetobacter baumannii | - |
nicotinate + NH3 | - |
? | |
3.5.1.19 | pyrazinamide + H2O | Acinetobacter baumannii | a nicotinamide prodrug. In Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid, hence the alternative name, pyrazinamidase, PncA | pyrazinoic acid + NH3 | a bacteriostatic drug | ? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.B15 | Acinetobacter baumannii | - |
- |
- |
3.5.1.19 | Acinetobacter baumannii | - |
- |
- |
EC Number | Reaction | Comment | Organism | Reaction ID |
---|---|---|---|---|
3.5.1.19 | nicotinamide + H2O = nicotinate + NH3 | the active site Cys159, conserved and essential, is located at the N-terminus of a6 at one side of the active site with the Zn2+ ion positioned on the other side. The metal ion is bound tightly in the AbPncA active site. The reaction proceeds in a four-stage mechanism via a tetrahedral and an acyl intermediate, overview | Acinetobacter baumannii |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.B15 | pyrazinamide + H2O | a nicotinamide prodrug. In Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid | Acinetobacter baumannii | pyrazinoic acid + NH3 | a bacteriostatic drug | ? | |
3.5.1.19 | nicotinamide + H2O | - |
Acinetobacter baumannii | nicotinate + NH3 | - |
? | |
3.5.1.19 | nicotinamide + H2O | active site structure, overview | Acinetobacter baumannii | nicotinate + NH3 | - |
? | |
3.5.1.19 | pyrazinamide + H2O | a nicotinamide prodrug. In Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid, hence the alternative name, pyrazinamidase, PncA | Acinetobacter baumannii | pyrazinoic acid + NH3 | a bacteriostatic drug | ? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.5.1.B15 | dimer | - |
Acinetobacter baumannii |
3.5.1.19 | dimer | - |
Acinetobacter baumannii |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.B15 | PncA | - |
Acinetobacter baumannii |
3.5.1.B15 | pyrazinamidase | - |
Acinetobacter baumannii |
3.5.1.19 | PncA | - |
Acinetobacter baumannii |
3.5.1.19 | pyrazinamidase | - |
Acinetobacter baumannii |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.5.1.B15 | metabolism | in Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid | Acinetobacter baumannii |
3.5.1.B15 | physiological function | the reaction product pyrazinoic acid inhibits Mycobacterium tuberculosis type I fatty acid synthase, represses mycolic acid biosynthesis, and appears to affect membrane energetics and acidification of the cytoplasm | Acinetobacter baumannii |
3.5.1.19 | metabolism | the enzyme catalyzes the deamination of nicotinamide, which is an important step in the NAD+ salvage pathway. In Mycobacterium tuberculosis the enzyme converts the nicotinamide analogue prodrug pyrazinamide into the bacteriostatic pyrazinoic acid, hence the alternative name, pyrazinamidase, PncA | Acinetobacter baumannii |
3.5.1.19 | physiological function | the reaction product pyrazinoic acid inhibits Mycobacterium tuberculosis type I fatty acid synthase, represses mycolic acid biosynthesis, and appears to affect membrane energetics and acidification of the cytoplasm | Acinetobacter baumannii |